BPG is committed to discovery and dissemination of knowledge
Featured Articles
10/14/2020 12:23:38 PM | Browse: 629 | Download: 1479
 |
Received |
|
2020-04-19 14:47 |
|
Peer-Review Started |
|
2020-04-19 14:48 |
|
First Decision by Editorial Office Director |
|
2020-05-20 06:29 |
|
Return for Revision |
|
2020-05-20 06:29 |
|
Revised |
|
2020-05-25 09:15 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2020-08-25 07:22 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2020-08-26 04:46 |
|
Articles in Press |
|
2020-08-26 04:46 |
|
Edit the Manuscript by Language Editor |
|
2020-09-05 01:54 |
|
Typeset the Manuscript |
|
2020-10-13 06:24 |
|
Publish the Manuscript Online |
|
2020-10-14 09:17 |
| ISSN |
1948-9358 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Infectious Diseases |
| Manuscript Type |
Meta-Analysis |
| Article Title |
Prevalence and impact of diabetes in patients with COVID-19 in China
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Min Du, Yu-Xin Lin, Wen-Xin Yan, Li-Yuan Tao, Min Liu and Jue Liu |
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| National Natural Science Foundation of China |
71934002 |
|
| Corresponding Author |
Jue Liu, PhD, Associate Professor, Department of Epidemiology and Biostatistics, School of Public Health, Peking University, No. 38 Xueyuan Road, Haidian District, Beijng 100191, China. liujue7@163.com |
| Key Words |
Diabetes; COVID-19; Systematic review; Meta-analysis; Prevalence; Impact |
| Core Tip |
At present, the prevalence and impact of diabetes on coronavirus disease 2019 (COVID-19) infection has not been systematically reviewed in China. This meta-analysis firstly focused on the pooled prevalence of diabetes among COVID-19 patients and its impact on clinical outcomes (ICU admission, severity and death) in China. The analysis showed that the pooled prevalence of diabetes was 10% [95% confidence interval (CI): 7%-15%] in COVID-19 patients. Besides, the risk of severe cases (risk ratio = 2.13, 95%CI: 1.76-2.56, I2 = 49%, P = 0.007) and deaths (risk ratio = 3.16, 95%CI: 2.64-3.78, I2 = 34%, P = 0.20) were both higher in COVID-19 patients with diabetes compared with patients without diabetes. It highlights the need for targeted intervention on diabetes among COVID-19 patients. |
| Publish Date |
2020-10-14 09:17 |
| Citation |
Du M, Lin Y, Yan W, Tao L, Liu M, Liu J. Prevalence and impact of diabetes in patients with COVID-19 in China. World J Diabetes 2020; 11(10): 468-480 |
| URL |
https://www.wjgnet.com/1948-9358/full/v11/i10/468.htm |
| DOI |
https://dx.doi.org/10.4239/wjd.v11.i10.468 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
